scispace - formally typeset
A

Alison Goate

Researcher at Icahn School of Medicine at Mount Sinai

Publications -  781
Citations -  98332

Alison Goate is an academic researcher from Icahn School of Medicine at Mount Sinai. The author has contributed to research in topics: Genome-wide association study & Alzheimer's disease. The author has an hindex of 136, co-authored 721 publications receiving 85846 citations. Previous affiliations of Alison Goate include St Mary's Hospital & Brown University.

Papers
More filters
Journal ArticleDOI

Coding variants in TREM2 increase risk for Alzheimer's disease

TL;DR: Gene-based tests demonstrate variants in TREM2 are genome-wide significantly associated with AD, and gel electrophoresis analysis confirms that at least three T REM2 transcripts are expressed in human brains, including one encoding a soluble form of TREM1.
Journal ArticleDOI

Exercise Engagement as a Moderator of the Effects of APOE Genotype on Amyloid Deposition.

TL;DR: Cognitively normal sedentary APOE ε4-positive individuals may be at augmented risk for cerebral amyloid deposition, and a novel interaction between APOE status and exercise engagement for [(11)C]PiB binding is observed.
Journal ArticleDOI

Genetic association between intronic polymorphism in presenilin-1 gene and late-onset Alzheimer's disease

TL;DR: In the white series of cases, PS-1 accounted for about half as much of the risk for late-onset Alzheimer's disease as did ApoE4, and the smaller African-American series showed similar distribution of PS- 1 genotype between cases and controls.
Journal ArticleDOI

A novel Alzheimer disease locus located near the gene encoding tau protein

Gyungah Jun, +450 more
- 01 Jan 2016 - 
TL;DR: The authors' APOE-stratified GWAS is the first to show GWS association for AD with SNPs in the chromosome 17q21.31 region, and the finding in the stage 1 sample that AD risk is significantly influenced by the interaction of APOE with TMEM106B (P=1·6 × 10−7) is noteworthy, because TMEM 106B variants have previously been associated with risk of frontotemporal dementia.
Journal ArticleDOI

Statement on Use of Apolipoprotein E Testing for Alzheimer Disease

TL;DR: There is general consensus that APOE epsilon 4 is strongly associated with AD and that when present may represent an important risk factor for the disease, however, at the present time it is not recommended for use in routine clinical diagnosis nor should it be used for predictive testing.